J&J Gets FDA Nod for Plaque Psoriasis Pill Positioned to Compete With Injectables

FDA approval of Icotyde covers the treatment of adults and adolescents with moderate-to-severe plaque psoriasis. This once-daily pill, developed by partners Johnson & Johnson and Protagonist Therapeutics, offers an easier dosing option compared to injectables and is projected to become a blockbuster seller across several immunological indications. The post J&J Gets FDA Nod for Plaque…

Read More

3 Rules Health Systems Are Living By in 2025

Healthcare experts shared key principles that are guiding health system strategy during a panel at MedCity News’ INVEST conference. These leaders believe in flexible, patient-centered engagement strategies, emphasize clinical value as the benchmark for adopting technology, and champion collaboration to scale solutions that deliver proven results. The post 3 Rules Health Systems Are Living By…

Read More

Why One Investor Still Believes in Retail Health

It’s been a tumultuous past couple years for retail health companies —but there are still reasons to believe in the convenient model that retail health offers, said Annie Lamont, managing partner and co-founder of Oak HC/FT. The post Why One Investor Still Believes in Retail Health appeared first on MedCity News.

Read More

How come I owe Labcorp $34.94? (Part 3)

By MATTHEW HOLT For those of you waiting for the Labcorp, Blue Shield of California, Brown & Toland Physicians Physicians update, the ball has been moved a couple of years down the field. If you want to catch up here is part 1, part 2 and part 3) You’ll recall we left it with a mystery…

Read More